FABP
FABP(脂肪酸结合蛋白)
Fatty acid-binding proteins (FABPs) are members of the intracellular lipid-binding protein (iLBP) family and are involved in reversibly binding intracellular hydrophobic ligands and trafficking them throughout cellular compartments, including the peroxisomes, mitochondria, endoplasmic reticulum and nucleus. FABPs are small, structurally conserved cytosolic proteins consisting of a water-filled, interior-binding pocket surrounded by ten anti-parallel beta sheets, forming a beta barrel. At the superior surface, two alpha-helices cap the pocket and are thought to regulate binding. FABPs have broad specificity, including the ability to bind long-chain (C16-C20) fatty acids, eicosanoids, bile salts and peroxisome proliferators.
FABPs are ubiquitously expressed throughout tissues that are highly active in FA metabolism and comprise several isoforms. To date, nine FABP protein-coding genes have been identified in the human genome. These include liver (L-FABP), intestine- (I-FABP), heart- (H-FABP), adipocyte- (A-FABP), epidermal- (E-FABP), ileal- (Il-FABP), brain- (B-FABP), myelin- (M-FABP) and testis-FABP (T-FABP).
FABP 相关产品(8)
- GC11894BMS 309403CAS: 300657-03-8纯度: >99.50% / >98.00%
BMS 309403是一种强效、具有口服活性且选择性的adipocyte fatty acid binding protein (FABP4)抑制剂,IC 50 值为0.71μM。
- GC36432LDN-0088050CAS: 353484-30-7
LDN 0088050 是一种选择性的脂肪酸结合蛋白 (AFABP, FABP4) 抑制剂,FABP4、FABP3 的 Ki 值分别为 0.29、1.3 μM. LDN 0088050 结合 FABP4 的Kd 值为 2.05 μM。
- GC61783BMS-309403 sodiumCAS: 2802523-05-1纯度: >98.50%
A cell- permeable, potent, and selective inhibitor of FABP4
- GC65322FABPs ligand 6CAS: 2988135-14-2纯度: >98.00%
FABPs ligand 6是一种FABP5和FABP7抑制剂,对FABP5和FABP7的K d 值分别为874nM和20nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11894 | BMS 309403 | 300657-03-8 | >99.50% / >98.00% | |
BMS 309403是一种强效、具有口服活性且选择性的adipocyte fatty acid binding protein (FABP4)抑制剂,IC 50 值为0.71μM。 | ||||
| GC31356 | HTS01037 | 682741-29-3 | >99.50% | |
An antagonist of A- FABP/aP2 protein- protein interactions | ||||
| GC36432 | LDN-0088050 | 353484-30-7 | - | |
LDN 0088050 是一种选择性的脂肪酸结合蛋白 (AFABP, FABP4) 抑制剂,FABP4、FABP3 的 Ki 值分别为 0.29、1.3 μM. LDN 0088050 结合 FABP4 的Kd 值为 2.05 μM。 | ||||
| GC50283 | HM 50316 | 1310361-52-4 | - | |
High affinity FABP4 inhibitor | ||||
| GC61783 | BMS-309403 sodium | 2802523-05-1 | >98.50% | |
A cell- permeable, potent, and selective inhibitor of FABP4 | ||||
| GC62617 | FABP-IN-1 | 2132990-90-8 | >98.00% | |
FABP-IN-1(Compounds 4b) 是一种高亲和力脂肪酸结合蛋白 (FABP) 抑制剂。FABP-IN-1 抑制 FABP3,FABP5 和 FABP7 的 Ki 值分别为 0.69 μM,0.55 μM 和 0.67 μM,并具有有效的镇痛作用。 | ||||
| GC65322 | FABPs ligand 6 | 2988135-14-2 | >98.00% | |
FABPs ligand 6是一种FABP5和FABP7抑制剂,对FABP5和FABP7的K d 值分别为874nM和20nM。 | ||||
| GC73831 | ART26.12 | 2766800-24-0 | >99.00% | |
ART26.12是一种具有抗大麻素特性的口服活性FABP5抑制剂。 | ||||
